Moreover, our results indicated that HEG1 has great clinical significance in the early diagnosis, recurrence monitoring of adenocarcinoma, and has potential to be widely used in clinical practice as a tumor biomarker for diagnosis and prognosis of LUAD. Here, HEG1 is linked to adenocarcinoma.